SMTL ID : 5of0.1

X-ray structure of human glutamate carboxypeptidase II (GCPII), the E424M inactive mutant, in complex with a inhibitor CFBzOG

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.48 Å

Oligo State

homo-dimer

Ligands

6 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG-NAG.1: 5 residues within 4Å: Chain A: N.33, Q.36, Q.52, S.55, Q.56 2 PLIP interactions: 2 interactions with chain A Hydrophobic interactions: A:Q.52 Hydrogen bonds: A:S.55 NAG-NAG.2: 4 residues within 4Å: Chain A: N.78, T.80, H.81, T.306 No protein-ligand interaction detected (PLIP) NAG-NAG.3: 4 residues within 4Å: Chain A: Y.84, E.94, I.95, N.97 No protein-ligand interaction detected (PLIP) NAG-NAG.13: 5 residues within 4Å: Chain B: N.33, Q.36, Q.52, S.55, Q.56 2 PLIP interactions: 2 interactions with chain B Hydrophobic interactions: B:Q.52 Hydrogen bonds: B:S.55 NAG-NAG.14: 4 residues within 4Å: Chain B: N.78, T.80, H.81, T.306 No protein-ligand interaction detected (PLIP) NAG-NAG.15: 4 residues within 4Å: Chain B: Y.84, E.94, I.95, N.97 No protein-ligand interaction detected (PLIP)

2 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-BMA-MAN.4: 7 residues within 4Å: Chain A: S.429, L.430, N.433, P.551, Q.608, D.609, K.612 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:Q.608, A:K.612 NAG-NAG-BMA-MAN.16: 7 residues within 4Å: Chain B: S.429, L.430, N.433, P.551, Q.608, D.609, K.612 2 PLIP interactions: 2 interactions with chain B Hydrogen bonds: B:Q.608, B:K.612

2 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-BMA-MAN-MAN.5: 10 residues within 4Å: Chain A: S.588, S.591, A.592, N.595, Q.697 Chain B: L.67, H.69, E.233, Y.234, R.311 2 PLIP interactions: 2 interactions with chain B Hydrogen bonds: B:E.233, B:R.311, B:R.311, B:L.67, B:H.69 Water bridges: B:H.69 NAG-NAG-BMA-MAN-MAN.17: 10 residues within 4Å: Chain A: L.67, H.69, E.233, Y.234, R.311 Chain B: S.588, S.591, A.592, N.595, Q.697 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:E.233, A:R.311, A:R.311, A:L.67, A:H.69 Water bridges: A:H.69

4 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.6: 2 residues within 4Å: Chain A: N.152, S.154 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:S.154 NAG.7: 4 residues within 4Å: Chain A: W.203, N.416, F.522, Y.523 5 PLIP interactions: 5 interactions with chain A Hydrophobic interactions: A:W.203, A:Y.523 Hydrogen bonds: A:W.203, A:F.522 Water bridges: A:N.416 NAG.18: 2 residues within 4Å: Chain B: N.152, S.154 1 PLIP interactions: 1 interactions with chain B Hydrogen bonds: B:S.154 NAG.19: 4 residues within 4Å: Chain B: W.203, N.416, F.522, Y.523 5 PLIP interactions: 5 interactions with chain B Hydrophobic interactions: B:W.203, B:Y.523 Hydrogen bonds: B:W.203, B:F.522 Water bridges: B:N.416

4 x ZN: ZINC ION(Non-covalent)

ZN.8: 5 residues within 4Å: Chain A: D.344, E.382, H.510 Ligands: ZN.9, 9TB.12 5 PLIP interactions: 4 interactions with chain A, 1 Ligand-Water interactions Metal complexes: A:D.344, A:E.382, A:E.382, A:H.510, H2O.15 ZN.9: 6 residues within 4Å: Chain A: H.334, D.344, M.381, E.382, D.410 Ligands: ZN.8 5 PLIP interactions: 4 interactions with chain A, 1 Ligand-Water interactions Metal complexes: A:H.334, A:D.344, A:D.410, A:D.410, H2O.15 ZN.20: 5 residues within 4Å: Chain B: D.344, E.382, H.510 Ligands: ZN.21, 9TB.24 5 PLIP interactions: 4 interactions with chain B, 1 Ligand-Water interactions Metal complexes: B:D.344, B:E.382, B:E.382, B:H.510, H2O.39 ZN.21: 6 residues within 4Å: Chain B: H.334, D.344, M.381, E.382, D.410 Ligands: ZN.20 5 PLIP interactions: 4 interactions with chain B, 1 Ligand-Water interactions Metal complexes: B:H.334, B:D.344, B:D.410, B:D.410, H2O.39

2 x CA: CALCIUM ION(Non-covalent)

CA.10: 4 residues within 4Å: Chain A: T.226, Y.229, E.390, E.393 5 PLIP interactions: 5 interactions with chain A Metal complexes: A:T.226, A:Y.229, A:E.390, A:E.390, A:E.393 CA.22: 4 residues within 4Å: Chain B: T.226, Y.229, E.390, E.393 5 PLIP interactions: 5 interactions with chain B Metal complexes: B:T.226, B:Y.229, B:E.390, B:E.390, B:E.393

2 x CL: CHLORIDE ION(Non-functional Binders)

CL.11: 5 residues within 4Å: Chain A: N.408, D.410, R.491, R.493, R.537 Ligand excluded by PLIP CL.23: 5 residues within 4Å: Chain B: N.408, D.410, R.491, R.493, R.537 Ligand excluded by PLIP

2 x 9TB: (2~{S})-2-[[(2~{S})-6-[(4-fluorophenyl)methylamino]-1-oxidanyl-1,6-bis(oxidanylidene)hexan-2-yl]carbamoylamino]pentanedioic acid(Non-covalent)

9TB.12: 20 residues within 4Å: Chain A: F.166, R.167, N.214, M.381, E.382, G.384, L.385, D.410, R.420, D.422, G.475, N.476, R.491, R.493, F.503, Y.509, H.510, K.656, Y.657 Ligands: ZN.8 21 PLIP interactions: 21 interactions with chain A Hydrophobic interactions: A:R.420, A:R.493, A:Y.509, A:Y.657 Hydrogen bonds: A:N.214, A:S.411, A:G.475, A:G.475, A:N.476 Water bridges: A:N.214, A:R.491, A:R.491, A:R.491, A:K.656 Salt bridges: A:R.167, A:R.491, A:R.493, A:H.510, A:K.656 pi-Cation interactions: A:R.491 Halogen bonds: A:R.420 9TB.24: 20 residues within 4Å: Chain B: F.166, R.167, N.214, M.381, E.382, G.384, L.385, D.410, R.420, D.422, G.475, N.476, R.491, R.493, F.503, Y.509, H.510, K.656, Y.657 Ligands: ZN.20 21 PLIP interactions: 21 interactions with chain B Hydrophobic interactions: B:R.420, B:R.493, B:Y.509, B:Y.657 Hydrogen bonds: B:N.214, B:S.411, B:G.475, B:G.475, B:N.476 Water bridges: B:N.214, B:R.491, B:R.491, B:R.491, B:K.656 Salt bridges: B:R.167, B:R.491, B:R.493, B:H.510, B:K.656 pi-Cation interactions: B:R.491 Halogen bonds: B:R.420

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Nakajima, R. et al., 2-Aminoadipic Acid-C(O)-Glutamate Based Prostate-Specific Membrane Antigen Ligands for Potential Use as Theranostics. ACS Med Chem Lett (2018)

Release Date

2018-08-01

Peptides

Glutamate carboxypeptidase 2: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
A

Glutamate carboxypeptidase 2

Related Entries With Identical Sequence